Earnings History Data for Revolution Medicines, Inc. (RVMD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Revolution Medicines, Inc.
Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | AH | RVMD | Revolution Medicines, Inc. | 9,330 | -0.94 | -0.88 | -0.99 | Revolution Medicines GAAP EPS of -$0.94 misses by $0.04 [11/6/2024 4:14 PM] |
59.39 | -0.03 (-0.05%) |
58.81 | -0.61 (-1.03%) |
18.79 - 60.53 | 1,172,747 | 1,800,000 | 790 | ||
| 07-08-2024 | AH | RVMD | Revolution Medicines, Inc. | 7,260 | -0.81 | -0.77 | -0.92 | Revolution Medicines GAAP EPS of -$0.81 misses by $0.03 [8/7/2024 4:21 PM] |
41.96 | -0.31 (-0.73%) |
42.27 | 0.0 (0.00%) |
15.44 - 48.61 | 1,018,126 | 1,160,000 | 22,599 | ||
| 08-05-2024 | AH | RVMD | Revolution Medicines, Inc. | 6,430 | -0.70 | -0.75 | -0.72 | Revolution Medicines GAAP EPS of -$0.70 beats by $0.05 [5/8/2024 5:04 PM] |
37.31 | -1.00 (-2.61%) |
38.31 | 0.0 (0.00%) |
15.44 - 40.21 | 897,203 | 1,140,000 | 37,028 | ||
| 26-02-2024 | AH | RVMD | Revolution Medicines, Inc. | 3,180 | -1.14 | -0.85 | -0.63 | Revolution Medicines GAAP EPS of -$1.14 misses by $0.28, revenue of $0.7M misses by $0.5M [2/26/2024 4:19 PM] |
30.62 | 0.24 (0.79%) |
30.27 | -0.11 (-0.38%) |
15.44 - 35.60 | 2,410,191 | 1,140,000 | 1,217 | ||
| 06-11-2023 | AH | RVMD | Revolution Medicines, Inc. | 2,310 | -0.99 | -1.01 | -0.87 | Revolution Medicines GAAP EPS of $0.99 beats by $2.01, revenue of $0M misses by $0.86M [11/6/2023 4:27 PM] |
21.52 | -0.02 (-0.09%) |
21.54 | 0.0 (0.00%) |
15.44 - 35.60 | 1,683,299 | 3,070,000 | 21,235 | ||
| 08-08-2023 | AH | RVMD | Revolution Medicines, Inc. | 3,320 | -0.92 | -0.82 | -0.82 | Revolution Medicines GAAP EPS of -$0.92 misses by $0.09, revenue of $3.82M beats by $2.26M [8/8/2023 4:34 PM] |
29.66 | -0.51 (-1.69%) |
30.17 | 0.0 (0.00%) |
17.03 - 33.19 | 572,608 | 1,830,000 | 7,140 | ||
| 08-05-2023 | AH | 4:05 PM ET (May 8) |
RVMD | Revolution Medicines, Inc. | 2,570 | -0.72 | -0.84 | -0.78 | Revolution Medicines GAAP EPS of -$0.72 beats by $0.10, revenue of $7.01M beats by $4.07M [5/8/2023 4:18 PM] |
25.27 | 0.83 (3.40%) |
24.44 | 0.0 (0.00%) |
14.08 - 31.37 | 834,037 | 690,000 | 21,987 | |
| 27-02-2023 | AH | 4:05 PM ET (Feb 27) |
RVMD | Revolution Medicines, Inc. | 2,230 | -0.63 | -0.84 | -0.71 | Revolution Medicines GAAP EPS of -$0.63 beats by $0.18, revenue of $15.33M beats by $7.53M [2/27/2023 4:10 PM] |
26.77 | 2.40 (9.85%) |
28.00 | 3.63 (14.90%) |
14.08 - 31.37 | 4,990,141 | 910,000 | 102,402 | |
| 07-11-2022 | AH | 4:00 PM ET (Nov 7) |
RVMD | Revolution Medicines, Inc. | 1,810 | -0.87 | -0.87 | -0.72 | Revolution Medicines GAAP EPS of -$0.87 misses by $0.02, revenue of $3.4M misses by $2.94M [11/7/2022 4:22 PM] |
19.68 | -0.09 (-0.46%) |
19.77 | 0.0 (0.00%) |
14.08 - 34.10 | 493,231 | 590,000 | 12,367 | |
| 09-08-2022 | AH | 4:00 PM ET (Aug 9) |
RVMD | Revolution Medicines, Inc. | 1,660 | -0.82 | -0.87 | -0.60 | Revolution Medicines GAAP EPS of -$0.82 beats by $0.04, revenue of $9.11M beats by $2.09M [8/9/2022 4:07 PM] |
24.37 | 0.61 (2.57%) |
23.76 | 0.0 (0.00%) |
14.08 - 34.16 | 714,020 | 990,000 | 2,236 | |
| 09-05-2022 | AH | 4:05 PM ET (May 9) |
RVMD | Revolution Medicines, Inc. | 1,510 | -0.78 | -0.82 | -0.53 | Revolution Medicines GAAP EPS of -$0.78 beats by $0.01, revenue of $7.58M misses by $1M [5/9/2022 4:54 PM] |
16.05 | 1.06 (7.07%) |
14.99 | 0.0 (0.00%) |
14.46 - 35.07 | 659,501 | 657,041 | 22,179 | |
|
||||||||||||||||||
| 28-02-2022 | AH | 4:05 PM ET (Feb 28) |
RVMD | Revolution Medicines, Inc. | 1,460 | -0.71 | -0.65 | -0.52 | Revolution Medicines GAAP EPS of -$0.71 misses by $0.07, revenue of $9.46M misses by $0.49M [2/28/2022 4:37 PM] |
18.56 | -0.36 (-1.90%) |
20.09 | 1.17 (6.18%) |
18.07 - 50.88 | 478,688 | 460,000 | 256 | |
|
||||||||||||||||||
| 10-11-2021 | AH | 4:00 PM ET (Nov 10) |
RVMD | Revolution Medicines, Inc. | 2,480 | -0.72 | -0.62 | -0.42 | Revolution Medicines EPS misses by $0.10, misses on revenue [11/10/2021 4:17 PM] |
32.07 | 0.37 (1.17%) |
31.70 | 0.0 (0.00%) |
21.78 - 56.18 | 460,390 | 480,000 | 5,202 | |
| 11-08-2021 | AH | 4:05 PM ET (Aug 11) |
RVMD | Revolution Medicines, Inc. | 2,010 | -0.60 | -0.55 | -0.46 | Revolution Medicines EPS misses by $0.05, misses on revenue [8/11/2021 4:15 PM] |
23.95 | -2.95 (-10.97%) |
23.70 | -3.20 (-11.90%) |
21.78 - 56.18 | 3,239,567 | 500,000 | 3,361 | |
| 10-05-2021 | AH | 4:05 PM ET (May 10) |
RVMD | Revolution Medicines, Inc. | 2,130 | -0.53 | -0.52 | 0.00 | Revolution Medicines EPS misses by $0.01, beats on revenue [5/10/2021 4:40 PM] |
31.68 | 1.88 (6.31%) |
29.80 | 0.0 (0.00%) |
21.17 - 56.18 | 520,138 | 1,120,000 | 8,527 | |